TGF-β, PDGF-β, and CTGF mediate fibroblast/bone marrow transformation and reinforce the endothelial-fibroblast interface that is involved in fibroblast proliferation and capillary rarefaction in the pathological process of CKD. This evidence concerns the gene TGFB1 and chronic kidney disease.